ESR1 and osteoarthritis: In the ATZ-502-only treatment group, genes in the estrogen receptor signaling pathway, the osteoarthritis pathway, the H1F1a signaling pathway, and the pigment epithelium-derived factor signaling pathway were markedly activated.